Bharat Biotech Gets DCGI Panel's Approval For Phase 3 Trials Of Intranasal COVID-19 Vaccine As Booster Shot: Report
Bharat Biotech's Nasal Vaccine For Covid-19 Set To Advance Into Phase 2 Clinical Trial
Covid Vaccine Cocktail: Bharat Biotech To Test Covaxin-American Intranasal Candidate Combination In India
DCGI's Expert Panel Gives Go-Ahead To Bharat Biotech For Mixing Of COVAXIN And Nasal COVID-19 Vaccine In Trials
